| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |